The buyback is small relative to market cap and likely not a strong signal. Monitor future repurchase activity and the company's next quarterly update for pipeline progress on gamgertamig, which is the primary value driver.
Price Chart
Executive Summary
Lakefront Biotherapeutics disclosed the repurchase of 77,667 of its own ordinary shares between June 15-19, 2026, for a total of approximately €1.92 million, under a previously announced buyback program. The company now holds 116,204 treasury shares. This is a routine capital allocation disclosure with no material financial impact.
Key Facts
- Repurchased 77,667 shares between June 15-19, 2026 at an average price of €24.6586 per share.
- Total consideration for the repurchases was approximately €1,915,162.
- As of June 19, 2026, Lakefront holds 116,204 of its own ordinary shares.
- The repurchase program was announced on June 9, 2026.
Financial Impact
Approximately €1.92 million spent on share repurchases over five trading days, representing about 0.1% of the company's $1.9B market cap.
Risk Factors
- Buyback program may not be sustained or expanded.
- Company's clinical-stage pipeline (gamgertamig) carries inherent development risk.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001171843-26-004277 |
| Document: f6k_062426.htm | 0001171843-26-004277 |
| Document: 0001171843-26-004277-index-headers.html | 0001171843-26-004277 |
| Document: 0001171843-26-004277-index.html | 0001171843-26-004277 |
| Document: 0001171843-26-004277.txt | 0001171843-26-004277 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 20, 2026 6d ago | 6-K | $30.58 | awaiting T+20 | — | $31.56 (+3.20%) |
Oct 14, 2026 12d ago | 6-K | $29.93 | awaiting T+20 | — | $31.56 (+5.45%) |
Oct 13, 2026 13d ago | 6-K | $29.40 | awaiting T+20 | — | $31.56 (+7.35%) |
Oct 6, 2026 20d ago | 6-K | $30.00 | awaiting T+20 | — | $31.56 (+5.20%) |
Sep 1, 2026 7w ago | 6-K | $28.81 $29.65 | ▲ +2.92% | ▲ +3.25% | $31.56 (+9.55%) |
Aug 25, 2026 9w ago | 6-K | $29.70 $30.72 | ▲ +3.43% | ▲ +2.46% | $31.56 (+6.26%) |
Aug 12, 2026 10w ago | 6-K | $27.93 $26.81 | ▼ −4.01% | ▼ −2.11% | $31.56 (+13.00%) |
Jul 28, 2026 12w ago | 6-K | $27.72 $29.16 | ▲ +5.19% | ▲ +0.17% | $31.56 (+13.85%) |
Jun 30, 2026 16w ago | 6-K | $29.60 $27.72 | ▼ −6.35% | ▼ −4.17% | $31.56 (+6.62%) |
Jun 24, 2026 17w ago | 6-K | $29.01 $28.78 | ▼ −0.79% | ▼ −2.73% | $31.56 (+8.79%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers